Amgen Inc. (NASDAQ: AMGN) Stock Rating Reiterated at Jefferies Group

Analysts at Jefferies Group reiterated a Buy rating on shares of Amgen Inc. (NASDAQ: AMGN) in a reserach note to investors, making it one of the more actively watched stocks on Wall Street.With a rating of Buy on the shares, the company has a 52-week high of $176.64. The one-year price target of $190.56 is higher than the opening price of $172.94, causing a fair amount of other analysts to issue statements on the company recently. Share prices sometimes get a bounce to the upside when analysts reiterate coverage.

U.S. stocks on Monday closed essentially flat, after trading firmly higher, in a volatile session ahead of the start of a pair of closely watched central-bank policy meetings.

The Dow Jones Industrial Average DJIA, -0.02% closed down 3.63 points at 18,120.17.

The blue-chip index had been up by as much as 131 points earlier and traded within a 162-point range.

The S&P 500 SPX, +0.00% slipped 0.04 points to close at 2,139.12, after trading within an 18-point range

Meanwhile, the Nasdaq Composite Index COMP, -0.18% declined 9.54 points, or 0.2%, to close at 5,235.03.

Earlier, the index had been up by as many as 37 points and traded with a 58-point range

Shares of Amgen Inc. (NASDAQ: AMGN) opened at $172.94 yesterday trading between $172.46 and $173.40, and last traded at $173.33, which represents an increase of $1.95 compared to the previous closing price.

Amgen Inc. (NASDAQ: AMGN) now has a market cap of 129.71B.

558,709 shares traded hands yesterday, 43 percent below the average, out of a total float 747,320,000. Swing traders often use upticks in trading volume to pinpoint large volume aggregation or circulation by institutional investors, so look for trading volume to pick up in the coming days.

While higher trading for short periods will not mean much, conversely, a trend of heavy trading volume on the buy side over a series of days or weeks sends a positive cue to market traders that institutions may be moving in, so institutional sponsorship is crucial.

Institutional sponsorship commonly refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Institutional investors such as these retain substantial teams of analysts that research thousands of stocks, so it is good confirmation to see them taking a postion in a stock you’re researching.

By tracking the activity of these professional investors and how they influence moving averages,it allows for traders to make more useful decisions on trades.

With that in mind, Amgen Inc. (NASDAQ: AMGN) now has a 50-day MA of $172.00 and 200-day MA of $159.47. It has traded in a 52-week range between $130.09 – 176.64 and today’s last price is 0.02% lower than the 52 week high of $176.64.

Indeed, earnings growth is among the most critical things to look at in regards to stock investing and, accordingly, investors seek companies that have grown their earnings at least 25% or more for the past 3 years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.